BLSH compared with PACB: revenue, margins and what each company keeps, and the suppliers and customers both name

BLSHBullish

Mkt capRevenueRevenue

PACBPacific Biosciences of California, Inc.

Mkt capRevenueRevenue

Compare

BLSHBullish

PACBPacific Biosciences of California, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only BLSH 4

—Deloitte & Touche LLPunlistedsupplier

—BitGounlistedsupplier

—Fireblocksunlistedsupplier

—SPV KYunlistedsupplier

Shared 0

No shared counterparties.

Only PACB 2

—Illumina Cambridgeunlistedsupplier

—Buyerunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

BLSHBullish

20.65· pre 21.25· delayed

Mkt cap$3.1BRevenue—Revenue—

PACBPacific Biosciences of California, Inc.

2.43· pre 2.41· delayed

Pre-marketNov 6 '26delayed

Mkt cap$792.6MRevenue$41MQ3 FY26Revenue$160MFY25

Compare

Pre-marketNov 6 '26delayed

BLSHBullish

PACBPacific Biosciences of California, Inc.

20.65pre 21.25delayed

Price

2.43pre 2.41delayed

$3.1B

Mkt cap

$792.6M

—

Revenue

$41MQ3 FY26

—

Revenue

$160MFY25

BLSH20.65vsPACB2.43Pre-marketNov 6 '26delayed